Tirzepatide vs Semaglutide for Weight Loss

Feature Mounjaro (Tirzepatide) Ozempic (Semaglutide)
Manufacturer
Eli Lilly & Company
Novo Nordisk
Drug class
Dual GIP/GLP-1 receptor agonist
GLP-1 receptor agonist
FDA use
Type 2 diabetes
Type 2 diabetes
Off-label use
Weight loss (formally approved as Zepbound)
Weight loss (approved as Wegovy for obesity)
Administration
Weekly injection
Weekly injection

Mounjaro vs Ozempic — How They Compare for Weight Loss

When exploring medical weight-loss options, two injectable medications have stood out in recent years: Mounjaro (tirzepatide) and Ozempic (semaglutide). Originally developed to manage type 2 diabetes, both have shown meaningful effects on appetite suppression and weight reduction — making them highly searched treatments in Singapore and globally.

Medical illustration representing 1024x427 in a clinical setting

Mechanism of Action — What Makes Them Different

This dual hormone action is a key reason why Mounjaro often demonstrates higher efficacy in weight loss outcomes.

Weight Loss Results — Clinical Evidence

Across multiple comparative studies and trials:

These findings reflect typical clinical outcomes, though real-world results may vary based on individual biology, dosage, lifestyle changes, and treatment duration.

Side Effects — Similar but Not Identical

Both medications share common gastrointestinal side effects, such as nausea, vomiting, bloating and diarrhoea — especially early during treatment as the body adjusts.

Any injectable treatment should be initiated and monitored under medical supervision to manage side effects safely.

Clinical illustration relating to tirzepatide vs semaglutide for weight loss

Practical Considerations

Approved Uses
Dosage & Administration
Availability in Singapore

Choosing Between Them — What Matters Most

Your choice depends on goals, health profile and clinician guidance

Always consult a doctor to tailor dosing, review contraindications, and support adherence.

Medical professional holding an injection pen for diabetes or weight loss

Summary Table — Quick Comparison

Feature Mounjaro (Tirzepatide) Ozempic (Semaglutide)
Hormone Target
Dual (GLP-1 + GIP)
Single (GLP-1)
Weight Loss Efficacy
Higher (~20%+)
Moderate (~10–15%)
Side Effect Profile
Similar GI effects
Similar GI effects
Approved for Diabetes
Yes
Yes
Approved for Weight Loss
Off-label / evolving
Off-label (Wegovy is the semaglutide weight-loss branded option)

Contact Us

Book An Appointment Now

Take the first step toward a healthier, more confident you. Our medical team is ready to answer your questions and guide you through safe, personalised weight-loss options. Reach out today to schedule a consultation or speak with our care specialists.